This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by LIU, L. Articles by SHERINS, R. J. Search for Related Content PubMed PubMed Citation Articles by LIU, L. Articles by SHERINS, R. J.

Chronic Sex Steroid Exposure Increases Mean Plasma Growth Hormone Concentration and Pulse Amplitude in Men with Isolated Hypogonadotropic Hypogonadism

Developmental Endocrinology Branch, National Institute of Child Health and Human Development Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Linda Liu, M.D., Developmental Endocrinology Branch, National Institute of Child Health and Human Development, Building 10, Room 10 N262, 9000 Rockville Pike, Bethesda, Maryland 20892.

Sex steroid administration can increase the GH response to provocative stimuli, but the relationship of sex steroids to spontaneous GH secretion is still controversial. We sought to characterize the effect of sex steroids on the plasma GH concentration by examining the 24-h pattern of episodic GH secretion in nine previously untreated adult men with isolated hypogonadotropic hypogonadism before and during long term testosterone, gonadotropin, or pulsatile GnRH treatment. After chronic sex steroid exposure, the mean 24-h plasma GH level, mean GH pulse amplitude, and mean area under the curve of pulses were significantly increased compared to pretreatment values [3.2 ± 1.8 (±SD) vs. 1,8 ± 1.2 ng/mL (P < 0.01); 11.4 ± 7.2 vs. 5.5 ± 4.4 ng/mL (P < 0.05); and 720 ± 547 vs. 316 ± 371 ng/mL·20 min (P < 0.05), respectively], while mean 24-h pre-arid posttreatment GH pulse frequencies were indistinguishable (5.7 ± 2.1 posttreatment vs. 5.0 ± 3.2 pretreatment; P = NS). The mean posttreatment plasma somatomedin-C level also rose significantly during treatment (1.89 ± 0.65 vs. 1.28 ± 0.48 U/mL; P < 0.01). We conclude that the increase in the mean plasma GH level during chronic sex steroid exposure is due mainly to augmentation of GH pulse amplitude, and that sex steroids probably increase spontaneous GH secretion.

Received July 17, 1986.

This article has been cited by other articles:

				J. D. Veldhuis and C. Y. Bowers Factors Other than Sex Steroids Modulate GHRH and GHRP-2 Efficacies in Men: Evaluation Using a GnRH Agonist/Testosterone Clamp J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2544 - 2550. [Abstract] [Full Text] [PDF]

				G. Fanciulli, A. Delitala, and G. Delitala Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone Hum. Reprod. Update, May 1, 2009; 15(3): 341 - 358. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, K. L. Mielke, M. Cosma, C. Soares-Welch, R. Paulo, J. M. Miles, and C. Y. Bowers Aromatase and 5{alpha}-Reductase Inhibition during an Exogenous Testosterone Clamp Unveils Selective Sex Steroid Modulation of Somatostatin and Growth Hormone Secretagogue Actions in Healthy Older Men J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 973 - 981. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, D. M. Keenan, J. N. Bailey, A. Adeniji, J. M. Miles, R. Paulo, M. Cosma, and C. Soares-Welch Testosterone Supplementation in Older Men Restrains Insulin-Like Growth Factor's Dose-Dependent Feedback Inhibition of Pulsatile Growth Hormone Secretion J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 246 - 254. [Abstract] [Full Text] [PDF]

				A. L. Utz, A. Yamamoto, P. Sluss, J. Breu, and K. K. Miller Androgens May Mediate a Relative Preservation of IGF-I Levels in Overweight and Obese Women Despite Reduced Growth Hormone Secretion J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4033 - 4040. [Abstract] [Full Text] [PDF]

				R. C. Paulo, M. Cosma, C. Soares-Welch, J. N. Bailey, K. L. Mielke, J. M. Miles, C. Y. Bowers, and J. D. Veldhuis Gonadal Status and Body Mass Index Jointly Determine Growth Hormone (GH)-Releasing Hormone/GH-Releasing Peptide Synergy in Healthy Men J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 944 - 950. [Abstract] [Full Text] [PDF]

				R. Muniyappa, J. D. Sorkin, J. D. Veldhuis, S. M. Harman, T. Munzer, S. Bhasin, and M. R. Blackman Long-term testosterone supplementation augments overnight growth hormone secretion in healthy older men Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E769 - E775. [Abstract] [Full Text] [PDF]

				J. J. Christiansen, S. Fisker, C. H. Gravholt, P. Bennett, B. Svenstrup, M. Andersen, U. Feldt-Rasmussen, J. S. Christiansen, and J. O. L. Jorgensen Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I Eur. J. Endocrinol., May 1, 2005; 152(5): 719 - 726. [Abstract] [Full Text] [PDF]

				R. P A Rooman, L. O. De Beeck, M. Martin, J. van Doorn, S. Mohan, and M. V L Du Caju Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature Eur. J. Endocrinol., April 1, 2005; 152(4): 597 - 604. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF]

				J. J. Orrego, E. Dimaraki, K. Symons, and A. L. Barkan Physiological Testosterone Replenishment in Healthy Elderly Men Does Not Normalize Pituitary Growth Hormone Output: Evidence against the Connection between Senile Hypogonadism and Somatopause J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3255 - 3260. [Abstract] [Full Text] [PDF]

				S. Schurgin, S. Dolan, A. Perlstein, M. P. Sullivan, N. Aliabadi, and S. Grinspoon Effects of Testosterone Administration on Growth Hormone Pulse Dynamics in Human Immunodeficiency Virus-Infected Women J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3290 - 3297. [Abstract] [Full Text] [PDF]

				S. Dolan, S. Wilkie, N. Aliabadi, M. P. Sullivan, N. Basgoz, B. Davis, and S. Grinspoon Effects of Testosterone Administration in Human Immunodeficiency Virus-Infected Women With Low Weight: A Randomized Placebo-Controlled Study Arch Intern Med, April 26, 2004; 164(8): 897 - 904. [Abstract] [Full Text] [PDF]

				S. Nakamura, M. Mizuno, H. Katakami, A. C. Gore, and E. Terasawa Aging-Related Changes in in Vivo Release of Growth Hormone-Releasing Hormone and Somatostatin from the Stalk-Median Eminence in Female Rhesus Monkeys (Macaca mulatta) J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 827 - 833. [Abstract] [Full Text] [PDF]

				M. J. Woller, G. Everson-Binotto, E. Nichols, A. Acheson, K. L. Keen, C. Y. Bowers, and E. Terasawa Aging-Related Changes in Release of Growth Hormone and Luteinizing Hormone in Female Rhesus Monkeys J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5160 - 5167. [Abstract] [Full Text] [PDF]

				B.-A. Bengtsson, R. Abs, H. Bennmarker, J. P. Monson, U. Feldt-Rasmussen, E. Hernberg-Ståhl, B. Westberg, P. Wilton, and C. Wüster The Effects of Treatment and the Individual Responsiveness to Growth Hormone (GH) Replacement Therapy in 665 GH-Deficient Adults J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3929 - 3935. [Abstract] [Full Text]

				S. Grinspoon, C. Corcoran, T. Stanley, L. Katznelson, and A. Klibanski Effects of Androgen Administration on the Growth Hormone-Insulin-Like Growth Factor I Axis in Men with Acquired Immunodeficiency Syndrome Wasting J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4251 - 4256. [Abstract] [Full Text]

				D. A. Fryburg, A. Weltman, L. A. Jahn, J. Y. Weltman, E. Samojlik, R. L. Hintz, and J. D. Veldhuis Short-Term Modulation of the Androgen Milieu Alters Pulsatile, But Not Exercise- or Growth Hormone (GH)-Releasing Hormone-Stimulated GH Secretion in Healthy Men: Impact of Gonadal Steroid and GH Secretory Changes on Metabolic Outcomes J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3710 - 3719. [Abstract] [Full Text] [PDF]

				A. P. Cemeroglu, A. L. Barkan, G. B. Kletter, I. Z. Beitins, and C. M. Foster Changes in Serum Immunoreactive and Bioactive Growth Hormone Concentrations in Boys with Advancing Puberty and in Response to a 20-Hour Estradiol Infusion J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2166 - 2171. [Abstract] [Full Text] [PDF]

				A. Giustina, T. Scalvini, C. Tassi, P. Desenzani, C. Poiesi, W. B. Wehrenberg, A. D. Rogol, and J. D. Veldhuis Maturation of the Regulation of Growth Hormone Secretion in Young Males with Hypogonadotropic Hypogonadism Pharmacologically Exposed to Progressive Increments in Serum Testosterone J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1210 - 1219. [Abstract] [Full Text] [PDF]

				G. Johannsson, P. Marin, L. Lonn, M. Ottosson, K. Stenlof, P. Bjorntorp, L. Sjostrom, and B.-A. Bengtsson Growth Hormone Treatment of Abdominally Obese Men Reduces Abdominal Fat Mass, Improves Glucose and Lipoprotein Metabolism, and Reduces Diastolic Blood Pressure J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 727 - 734. [Abstract] [Full Text] [PDF]

				S. Loche, A. Colao, M. Cappa, J. Bellone, G. Aimaretti, G. Farello, A. Faedda, G. Lombardi, R. Deghenghi, and E. Ghigo The Growth Hormone Response to Hexarelin in Children: Reproducibility and Effect of Sex Steroids J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 861 - 864. [Abstract] [Full Text] [PDF]